Accendra Health, Inc. (ACH)
NYSE: ACH · Real-Time Price · USD
0.9509
-0.1491 (-13.55%)
At close: Aug 14, 2026, 4:00 PM EDT
0.9700
+0.0191 (2.01%)
After-hours: Aug 14, 2026, 7:59 PM EDT

Accendra Health Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, Accendra Health stock has a consensus rating of "Hold" and an average price target of $1.51. The average 1-year stock price forecast is 58.80% higher than the current stock price, while the lowest is $1.30 (+36.71%) and the highest is $1.75 (+84.04%).

Price Target: $1.51 (+58.80%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price$1.30$1.51$1.50$1.75
Change+36.71%+58.80%+57.75%+84.04%

Analyst Ratings

The average analyst rating for Accendra Health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy222220
Buy000000
Hold222224
Sell222222
Strong Sell000000
Total666666

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
UBS
UBS
Hold
Maintains
$4.5$1.5
HoldMaintains$4.5$1.5+57.75%Aug 13, 2026
Bank of America Securities
Bank of America Securities
Sell
Maintains
$2.7$1.3
SellMaintains$2.7$1.3+36.71%Aug 11, 2026
Robert W. Baird
Robert W. Baird
Hold
Downgrades
$6$1.5
HoldDowngrades$6$1.5+57.75%Aug 11, 2026
Citi
Citi
Hold
Downgrades
$4.5$1.5
HoldDowngrades$4.5$1.5+57.75%Aug 10, 2026

Financial Forecast

Revenue This Year
2.49B
from 2.76B
Decreased by -9.75%
Revenue Next Year
2.57B
from 2.49B
Increased by 2.98%
EPS This Year
0.01
from 1.01
Decreased by -99.32%
EPS Next Year
0.22
from 0.01
Increased by 3,020.69%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
9.79B9.96B2.55B2.68B2.76B2.49B
Revenue Growth
15.39%1.74%-74.36%5.00%3.06%-9.75%
Gross Profit
1.51B1.92B1.22B1.28B1.29B1.12B
Gross Margin
15.46%19.27%47.68%47.77%46.68%44.78%
Operating Income
402.60M288.89M155.31M156.47M146.21M155.56M
Net Income
221.59M22.39M-41.30M-362.69M-1.10B-143.80M
EPS
----1.010.01
EPS Growth
-----33.99%-99.32%
Forward PE
14.009.6411.287.863.38137.61
Dividend / Share
0.01----0.00
Free Cash Flow
102.03M395.04M563.85M96.36M671.68M231.00M
No. Analysts
-----6
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High2.5B
Avg2.5B
Low2.5B

Revenue Growth

Revenue Growth202620272028
High
-9.4%
Avg
-9.8%
Low
-10.2%

EPS Forecast

EPS202620272028
High0.07
Avg0.01
Low-0.04

EPS Growth

EPS Growth202620272028
High
-93.3%
Avg
-99.3%
Low-